Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

Clinical trial NCT02360709 · UNKNOWN

Trial details

NCT number: NCT02360709
Sponsor: CID S.p.A.
Status: UNKNOWN
Study type: OBSERVATIONAL

Coronary Artery Disease

Start date: 2014-11-01
Primary completion: 2017-01-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.